A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors
Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
Protocol YY-20394-003 is a phase I single arm, open label study. The primary objective is to
assess the safety of YY-20394 in subjects with advanced solid tumor. The secondary objective
is to determine the preliminary efficacy and pharmacokinetics (PK).